← Back to headlines
Cyprus Biotech Firm iDNA Genomics Reports Widened Losses to €3.46 Million
Cyprus-based biotechnology company iDNA Genomics Public Ltd announced that its audited consolidated financial statements for 2025 revealed a significant widening of losses to €3.46 million. The firm also reported a sharp deterioration in its balance sheet compared to the previous year.
10 Aug, 10:00 — 10 Aug, 10:00
